News Room Less than 1 min.Read Fly Play hf.: Financial Statement on European Single Electronic Format (ESEF) Fly Play hf.: Financial Statement on European Single Electronic Format (ESEF) By Investing Today February 21, 2025 FacebookTwitterPinterestWhatsApp Financial statements for 2024, now available in an additional ESEF-format. No changes in content. Attachment flyplayhf-2024-12-31-en 1 Powered by SlickText.com Hot this week News Room Transaction in Own Shares February 23, 2025 0 Transaction in Own Shares 21 February, 2025 ... News Room Prospera Energy Inc. Announces 2024 Year-End-Reserves February 23, 2025 0 CALGARY, Alberta, Feb. 22, 2025 (GLOBE NEWSWIRE)... News Room Excitement Builds at CPAC 2025 as President Donald J. Trump to Take Center Stage — FRANKSPEECH NETWORK, INC further known as Mike Lindell Media... February 22, 2025 0 It's not everyday the President of the United States... News Room Press Release: ECCO 2025: new duvakitug data reinforce best-in-class potential in ulcerative colitis and Crohn’s disease February 22, 2025 0 ECCO 2025: new duvakitug data reinforce best-in-class potential in... News Room Teva and Sanofi Present New Positive Phase 2b Study Results at ECCO 2025 Reinforcing Best-in-Class Potential of Duvakitug (Anti-TL1A) in Ulcerative Colitis and Crohn’s Disease February 22, 2025 0 Teva hosting investor call Monday, February 24 at 8:00... Topics News Room Transaction in Own Shares 0 Transaction in Own Shares 21 February, 2025 ... News Room Prospera Energy Inc. Announces 2024 Year-End-Reserves 0 CALGARY, Alberta, Feb. 22, 2025 (GLOBE NEWSWIRE)... News Room Excitement Builds at CPAC 2025 as President Donald J. Trump to Take Center Stage — FRANKSPEECH NETWORK, INC further known as Mike Lindell Media... 0 It's not everyday the President of the United States... News Room Press Release: ECCO 2025: new duvakitug data reinforce best-in-class potential in ulcerative colitis and Crohn’s disease 0 ECCO 2025: new duvakitug data reinforce best-in-class potential in... News Room Teva and Sanofi Present New Positive Phase 2b Study Results at ECCO 2025 Reinforcing Best-in-Class Potential of Duvakitug (Anti-TL1A) in Ulcerative Colitis and Crohn’s Disease 0 Teva hosting investor call Monday, February 24 at 8:00... News Room Sysco Halts All Purchases from Fort Wayne, Ind. Facility that Supplied Frozen Shakes Linked to Listeria Outbreak and Recalls Related Products 0 HOUSTON, Feb. 21, 2025 (GLOBE NEWSWIRE) --... News Room The Marketing Alliance Announces Financial Results for Quarter Ended December 31, 2024 0 ST. LOUIS, Feb. 21, 2025 (GLOBE NEWSWIRE)... News Room United Fire Group, Inc. Declares a Common Stock Quarterly Cash Dividend of $0.16 per Share 0 CEDAR RAPIDS, Iowa, Feb. 21, 2025 (GLOBE... Related Articles Transaction in Own Shares News Room February 23, 2025 Prospera Energy Inc. Announces 2024 Year-End-Reserves News Room February 23, 2025 Excitement Builds at CPAC 2025 as President Donald J. Trump to Take Center Stage — FRANKSPEECH NETWORK, INC further known as Mike Lindell Media... News Room February 22, 2025 Press Release: ECCO 2025: new duvakitug data reinforce best-in-class potential in ulcerative colitis and Crohn’s disease News Room February 22, 2025 Teva and Sanofi Present New Positive Phase 2b Study Results at ECCO 2025 Reinforcing Best-in-Class Potential of Duvakitug (Anti-TL1A) in Ulcerative Colitis and Crohn’s Disease News Room February 22, 2025 Popular Categories News RoomFeatured CompaniesVideos Previous articleLandsbankinn hf.: Competition Authority approves Landsbankinn’s purchase of TMNext articleCORR* Belships ASA: Mandatory notification of transactions by primary insiders and close associates and disclosure of large shareholdings